CHRISTINA ROBBINS: Open Payments
NPI 1831548411 · KAILUA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 46 payments from 12 companies in 2025. Trend: 2023 $1,603 · 2024 $834 · 2025 $1,166
Food & beverage: $1,156Education: $10
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $256 |
| UCB, Inc. | 4 | $190 |
| ABBVIE INC. | 12 | $178 |
| Galderma Laboratories, L.P. | 9 | $147 |
| Lilly USA, LLC | 4 | $121 |
| Amgen Inc. | 3 | $85 |
| GENZYME CORPORATION | 2 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| LEO Pharma Inc. | 1 | $24 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, OTEZLA, TALTZ, EBGLYSS, Sotyktu.
Industry payments across HI — which companies pay providers there.
